Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
30 days
×
Clear all
Filters
3
NCT07161414
2026-03-17
ARTEMIDE-subQ
AstraZeneca
Phase 1
Recruiting
40 enrolled
NCT05853367
2026-03-13
MK-0472-001
Merck Sharp & Dohme LLC
Phase 1
Recruiting
178 enrolled